small molecule

RIDAURA

AURANOFIN

Loss of exclusivityloss of exclusivity
CompanyLEGACY PHARMA INC SEZC

Drug detail

Brand nameRIDAURA
Active ingredientAURANOFIN
Strength3MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 1985
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

RIDAURA patent cliff — loss of exclusivity — | CliffBio